Small dense LDL-cholesterol determined by a simple precipitation assay for screening familial combined hyperlipidemia

Atherosclerosis

Volumn 205, Issue 2, 2009, Pages 603-607

  Hirano, Tsutomu ^a   Nohtomi, Kyoko ^a   Sato, Yoshikatsu ^b   Kamata, Kunio ^b   Ito, Yasuki ^b  

^a SHOWA UNIVERSITY   (Japan)

^b DENKA COMPANY LIMITED   (Japan)

Author keywords

ApolipoproteinB; Familial combined hyperlipidemia; Precipitation; Small dense LDL cholesterol; Triglyceride

Indexed keywords

APOLIPOPROTEIN B; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIAGNOSTIC VALUE; FAMILIAL HYPERLIPEMIA; FAMILY HISTORY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRECIPITATION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; APOLIPOPROTEINS B; CHOLESTEROL, LDL; ELECTROPHORESIS; FEMALE; HUMANS; HYPERLIPIDEMIA, FAMILIAL COMBINED; HYPERLIPIDEMIAS; MALE; MIDDLE AGED; NEPHELOMETRY AND TURBIDIMETRY; PHENOTYPE; RISK; TRIGLYCERIDES;

EID: 67650886223     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.01.009     Document Type: Article

References (25)

1. Goldstein J.L., Schrott H.G., Hazzard W.R., et al. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest 52 (1973) 1544-1568
2. Voors-Pette C., and de Bruin T.W. Excess coronary heart disease in Familial Combined Hyperlipidemia, in relation to genetic factors and central obesity. Atherosclerosis 157 (2001) 481-489
3. Sniderman A.D., Castro Cabezas M., Ribalta J., et al. A proposal to redefine familial combined hyperlipidaemia-third workshop on FCHL held in Barcelona from 3 to 5 May 2001, during the scientific sessions of the European Society for Clinical Investigation. Eur J Clin Invest 32 (2002) 71-73
4. Veerkamp M.J., de Graaf J., Bredie S.J., et al. Diagnosis of familial combined hyperlipidemia based on lipid phenotype expression in 32 families: results of a 5-year follow-up study. Arterioscler Thromb Vasc Biol 22 (2002) 274-282
5. Saito Y. The Japan Atherosclerosis Society Guidelines for Diagnosis and Treatment of Atherosclerotic Cardiovascular Disease 2002 (Editorial). J Atheroscler Thromb 11 (2004) 101-103
6. Teramoto T., Sasaki J., Ueshima H., et al. Primary hyperlipidemia. J Atheroscler Thromb 15 (2008) 49-51
7. Hirano T., Ito Y., and Yoshino G. Measurement of small dense low-density lipoprotein particles. J Atheroscler Thromb 12 (2005) 67-72
8. Hirano T., Ito Y., Saegusa H., et al. A novel and simple method for quantification of small, dense LDL. J Lipid Res 44 (2003) 2193-2201
9. Hirano T., Ito Y., Koba S., et al. Clinical significance of small dense low-density lipoprotein cholesterol levels determined by the simple precipitation method. Arterioscler Thromb Vasc Biol 24 (2004) 558-563
10. Nichols A.V., Krauss R.M., and Musliner T.A. Nondenaturing polyacrylamide gradient gel electrophoresis. Methods Enzymol 128 (1986) 417-433
11. Austin M.A., King M.C., and Vranizan K.M. Atherogenic lipoprotein phenotype A proposed genetic marker for coronary heart disease risk. Circulation 82 (1990) 495-506
12. Veerkamp M.J., de Graaf J., Hendriks J.C., et al. Nomogram to diagnose familial combined hyperlipidemia on the basis of results of a 5-year follow-up study. Circulation 109 (2004) 2980-2985
13. Pajukanta P., and Porkka K.V. Genetics of familial combined hyperlipidemia. Curr Atheroscler Rep 1 (1999) 79-86
14. Maruyama T., Yamashita S., MatsuzawaY, et al. Research Committee on Primary Hyperlipidemia of the Ministry of Health and Welfare of Japan Mutations in Japanese subjects with primary hyperlipidemia-results from the Research Committee of the Ministry of Health and Welfare of Japan since 1996. J Atheroscler Thromb 11 (2004) 131-145
15. Venkatesan S., Cullen P., Pacy P., et al. Stable isotopes show a direct relation between VLDL apoB overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia. Arterioscler Thromb 13 (1993) 1110-1118
16. Aguilar-Salinas C.A., Hugh P., and Barrett R. A familial combined hyperlipidemic kindred with impaired apolipoprotein B catabolism kinetics of apolipoprotein B during placebo and pravastatin therapy. Arterioscler Thromb Vasc Biol 17 (1997) 72-82
17. Georgieva A.M., van Greevenbroek M.M., Krauss R.M., et al. Subclasses of low-density lipoprotein and very low-density lipoprotein in familial combined hyperlipidemia: relationship to multiple lipoprotein phenotype. Arterioscler Thromb Vasc Biol 24 (2004) 744-749
18. Kwiterovich Jr. P.O., White S., Forte T., et al. Hyperapobetalipoproteinemia in a kindred with familial combined hyperlipidemia and familial hypercholesterolemia. Arteriosclerosis 7 (1987) 211-225
19. Sniderman A., Shapiro S., Marpole D., et al. Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins]. Proc Natl Acad Sci USA 77 (1980) 604-608
20. Ogita K., Ai M., Tanaka A., et al. Circadian rhythm of serum concentration of small dense low-density lipoprotein cholesterol. Clin Chim Acta 376 (2007) 96-100
21. Ogita K., Ai M., Tanaka A., et al. Serum concentration of small dense low-density lipoprotein-cholesterol during oral glucose tolerance test and oral fat tolerance test. Clin Chim Acta 387 (2008) 36-41
22. de Graaf J., Veerkamp M.J., and Stalenhoef A.F. Metabolic pathogenesis of familial combined hyperlipidaemia with emphasis on insulin resistance, adipose tissue metabolism and free fatty acids. J R Soc Med 12 Suppl. (2002) 46-53
23. Brouwers M.C., Cantor R.M., and Kono N. Heritability and genetic loci of fatty liver in familial combined hyperlipidemia. J Lipid Res 47 (2006) 2799-2807
24. Sniderman A., Bailey S.D., and Engert J.C. Familial combined hyperlipidaemia: how can genetic disorders be common, complex and comprehensible?. Clin Sci 113 (2007) 365-367
25. Koba S., Hirano T., Ito Y., et al. Significance of small dense low-density lipoprotein-cholesterol concentrations in relation to the severity of coronary heart diseases. Atherosclerosis 189 (2006) 206-214